Cargando…
Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
Randomized controlled trials have failed to report any survival advantage for WBRT combined with SRS in the management of brain metastases, despite the enhanced local and distant control in comparison to each treatment alone. Literature review have revealed important role of primary histology of the...
Autores principales: | Khan, Muhammad, Arooj, Sumbal, Li, Rong, Tian, Yunhong, Zhang, Jian, Lin, Jie, Liang, Yingying, Xu, Anan, Zheng, Ronghui, Liu, Mengzhong, Yuan, Yawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358601/ https://www.ncbi.nlm.nih.gov/pubmed/32733787 http://dx.doi.org/10.3389/fonc.2020.00781 |
Ejemplares similares
-
Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019) -
ALK Inhibitors in the Treatment of ALK Positive NSCLC
por: Khan, Muhammad, et al.
Publicado: (2019) -
Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma
por: Khan, Muhammad, et al.
Publicado: (2020) -
SRS in Combination With Ipilimumab: A Promising New Dimension for Treating
Melanoma Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2018) -
Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
por: Khan, Muhammad, et al.
Publicado: (2021)